BioMotiv LLC:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BioMotiv LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10469
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioMotiv LLC (BioMotiv) is a therapeutics licensing and development service provider. The company offers therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. It portfolio includes psoriasis, inflammatory bowel diseases, cancer, retinitis pigmentosa, anti-inflammatory, inflammatory diseases, chronic obstructive pulmonary disease, immuno-oncology and acute kidney injury, among others. BioMotiv serves inventors, investors, patients and physicians, among others. The company partners with harrington discovery institute, universities and research institutions, disease foundations, and industry sources. It offers research and development, and pre clinical services. BioMotiv is headquartered in Cleveland, Ohio, the US.

BioMotiv LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioMotiv LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMotiv LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioMotiv LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMotiv LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
BioMotiv LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioMotiv LLC, Medical Equipment, Deal Details 10
Venture Financing 10
BioMotiv Raises Additional USD30.5 Million in Venture Financing 10
BioMotiv Raises Additional USD4.8 Million in Venture Financing 11
BioMotiv Raises Additional USD1 Million in Venture Financing 12
BioMotiv LLC – Key Competitors 13
BioMotiv LLC – Key Employees 14
BioMotiv LLC – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 16
Recent Developments 17
Strategy And Business Planning 17
Apr 25, 2018: BioMotiv Expands with a New Office in Philadelphia 17
Mar 16, 2017: Nynex Therapeutics Launched to Target Oncogenic Proteins in the Treatment of Cancer 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
BioMotiv LLC, Medical Equipment, Key Facts 2
BioMotiv LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BioMotiv LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMotiv LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioMotiv LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMotiv LLC, Deals By Market, 2012 to YTD 2018 8
BioMotiv LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioMotiv Raises Additional USD30.5 Million in Venture Financing 10
BioMotiv Raises Additional USD4.8 Million in Venture Financing 11
BioMotiv Raises Additional USD1 Million in Venture Financing 12
BioMotiv LLC, Key Competitors 13
BioMotiv LLC, Key Employees 14
BioMotiv LLC, Other Locations 15
BioMotiv LLC, Subsidiaries 15
BioMotiv LLC, Joint Venture 16

List of Figures
BioMotiv LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BioMotiv LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BioMotiv LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BioMotiv LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BioMotiv LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMotiv LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
BioMotiv LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMotiv LLC, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[BioMotiv LLC:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orbus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orbus Therapeutics Inc (Orbus Therapeutics) is a clinical-stage biopharmaceutical company that develops and commercializes drugs for the treatment of anaplastic astrocytoma, a rare kind of cancer afflicting the central nervous system. Eflornithine, a cytostatic agent, indicated for the treat …
  • ABX Advanced Biochemical Compounds GmbH-製薬・医療分野:企業M&A・提携分析
    Summary ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a biochemical compounds provider that manufactures, develops, and distributes biochemicals for nuclear medicine. The company’s products include PET and SPECT precursors and reference standards, reagents …
  • Hwa Tai Industries Berhad:企業の戦略・SWOT・財務分析
    Hwa Tai Industries Berhad - Strategy, SWOT and Corporate Finance Report Summary Hwa Tai Industries Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Johnson Electric Holdings Limited (179):企業の財務・戦略的SWOT分析
    Johnson Electric Holdings Limited (179) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Dairyland Power Cooperative:企業の戦略的SWOT分析
    Dairyland Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Hokkaido Electric Power Co Inc (9509):企業の財務・戦略的SWOT分析
    Hokkaido Electric Power Co Inc (9509) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Neiman Marcus Group Ltd. LLC:企業の戦略的SWOT分析
    Neiman Marcus Group Ltd. LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • NUERNBERGER Beteiligungs-Aktiengesellschaft:企業の戦略・SWOT・財務情報
    NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Nordic Bioscience AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Nordic Bioscience AS (Nordic Bioscience), formerly Danish Biotech Co is a preclinical and clinical drug development company that offers serological biochemical solutions. The company offers diagnostic products, laboratory kits and biochemical assays. It provides degradation biomarkers, forma …
  • Ben E. Keith Company:戦略・SWOT・企業財務分析
    Ben E. Keith Company - Strategy, SWOT and Corporate Finance Report Summary Ben E. Keith Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Croma-Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company that offers development and commercialization of drugs in the field of aesthetic dermatology. The company’s products include princess skincare, princess injectables, and princess lift products. Its princess skincare products compri …
  • University of Texas MD Anderson Cancer Center:企業の戦略的SWOT分析
    University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • NEC Corp (6701):電力:M&Aディール及び事業提携情報
    Summary NEC Corp (NEC) provides information technology and network technologies solutions. The company’s product portfolio includes servers, equipment and network systems for telecommunication carriers, supercomputers, personal computers, tablet terminals, automated teller machines, storage devices, …
  • GAIL (India) Ltd (GAIL)-エネルギー分野:企業M&A・提携分析
    Summary GAIL (India) Ltd (GAIL) is a vertically integrated gas company that carries out exploration and production, transmission of natural gas. It also has presence in petrochemical, liquid hydrocarbons and power and renewable sectors. GAIL is also a major LPG transmission company, besides managing …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Agilvax Inc-製薬・医療分野:企業M&A・提携分析
    Summary Agilvax Inc (Agilvax) is a drug company that discovers and develops vaccines against infectious diseases and immunotherapies to treat cancer. The company develops products based on a proprietary virus-like particle platform technology. It develops immunotherapies to treat breast cancer, lung …
  • IMV Inc (IMV):製薬・医療:M&Aディール及び事業提携情報
    Summary IMV Inc (IMV), formerly Immunovaccine Inc, is a clinical-stage biopharmaceutical company that develops cancer immunotherapies and infectious disease vaccines. The company’s product candidates include DPX-Survivac, a T cell activating immunotherapy that identifies and disrupts cancer biology …
  • Lucigen Corp:医療機器:M&Aディール及び事業提携情報
    Summary Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vector …
  • PTT Public Company Limited:企業の戦略・SWOT・財務分析
    PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • QIAGEN N.V.:企業の戦略・SWOT・財務情報
    QIAGEN N.V. - Strategy, SWOT and Corporate Finance Report Summary QIAGEN N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆